Insights from C. elegans screening with SydLab™ One
ElixIRA Pharma partnered with Nagi Bioscience to evaluate the longevity potential of their lead candidates, E1 and E2, both individually and in combination, across a range of doses. Using our proprietary SydLab™ One platform and Nagi™ B-Age AI-powered assay, we conducted a conclusive study that generated critical insights into the synergistic effects of these compounds on lifespan and motility in C. elegans.
